Skip to content

A clinical trial to study the effects of dexamethasone nebulization and magnesium sulphate nebulization in patients with post operative sore throat.

A comparative study of pre-operative dexamethasone nebulization and magnesium sulphate nebulization in incidence and severity of post operative sore throat.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022499
Enrollment
80
Registered
2019-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexamethasone nebulization: patient will receive dexamethasone 8mg(2ml) with 3 ml of normal saline for nebulization Control Intervention1: Magnesium sulphate nebulization: patient will

Sponsors

INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES PATNA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patient willing to participate (2) Patient of ASA 1 & 2 physical status (3) Patient between 18-55 years of age of either sex (4) Patient with mallampati score 1 & 2

Exclusion criteria

Exclusion criteria: (1) Patient refusal to participate, (2) Patient with ASA physical status 3 and above (3) Patient aged less than 18 years and more than 55 years (4) Patient with suspected difficult airway and mallampati grade 3 & 4 (5) Patient with pregnancy,morbid obesity,h/o sore throat (6) Patient with failed intubation in two times

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of nebulized dexamethasone with that of magnesium sulphate in decreasing the incidence and severity of post operative sore throat.Timepoint: Incidence of post operative throat pain,hoarseness and cough will be assessed at 0hr,4hr,8hr,12hr and 24hr.

Secondary

MeasureTime frame
Adverse effects of dexamethasone and magnesium sulphate, if anyTimepoint: Upon discharge patient will be instructed to report when symptom appear

Countries

India

Contacts

Public ContactDr ARVIND KUMAR

Indira Gandhi Institute of Medical Sciences, Patna

ketyshweta@gmail.com7739132922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026